APS Logo

Development of clinical hyperspectral imaging system for head and neck tumors

ORAL

Abstract


Early-stage cancer detection and classification significantly increase the chances of successful treatment. In this study, we aim to develop a portable clinical hyperspectral imaging (HSI) system for the detection and classification of skin tumors in the head and neck region.



The tripod mounted system is based on a handheld hyperspectral camera (IQ, Specim, Finland) with an additional achromatic doublet lens to achieve sub-millimeter spatial resolution. The imaging regions were illuminated with a halogen lamp coupled to a ring illuminator providing bright and homogenous illumination. Tissue topography was also captured using two time-of-flight cameras (flexx2, PMD, Germany).



Three types of tumors were imaged in the study: benign papillary nevi, and malignant basal and squamous cell carcinomas. Hyperspectral images were analyzed using tissue indices, a metric that estimates various tissue properties, including melanin content, blood content, and oxygenation. Preliminary results show significant differences between tissues: malignant tumors have less melanin than benign ones (p<0.05) and tumors differ from healthy tissue in oxygenation (p<0.02).



Results show that a portable clinical HSI system could assist in early tumor detection, leading to better treatment outcome.

Presenters

  • Črt Keber

    University of Ljubljana, Faculty of Mathematics and Physics

Authors

  • Črt Keber

    University of Ljubljana, Faculty of Mathematics and Physics

  • Aljosa Krt

    General hospital Izola

  • Crt Jamsek

    Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana

  • Tadej Tomanic

    University of Ljubljana

  • Jost Stergar

    J. Stefan Institute, Jožef Stefan Institute

  • Tim Bozic

    Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia, Institute of Oncology Ljubljana

  • Bostjan Markelc

    Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia, Institute of Oncology Ljubljana

  • Ales Groselj

    Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana

  • Gregor Sersa

    Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia, Institute of Oncology Ljubljana

  • Matija Milanic

    University of Ljubljana